@ Astron Research
Research Limited, a leading IP oriented pharma contract research organization, is a fast growing Pharma Contract Research Organisation (CRO) with
a strong quest to deliver best services to the rapidly growing Healthcare
industry and has embarked its presence as a prominent global CRO.
The Company was established in the year 2001 with an objective to
provide prompt and reliable services to Pharma sector worldwide
and improve the product quality with the help of Technological Innovations
and Upgradations. Astron commenced its UK operations in 2004 for
Quality Testing and QP Release of finished formulations and API.
This facility is now UK-MHRA approved.
The Company has products and technology are sold in over 50 countries,
which includes European Union, US, Canada Australia, New Zealand,
South Africa, Brazil, Mexico, Middle East & North African countries.
45 ANDAs filed in US and 64 EU CTD dossiers developed till 2010.
The Global turnover registered a growth of 40% in the current financial
year with the contribution of European market being 50%.
The company is capable of handling Formulation and Analytical Research
of Solid Orals, Injectables, Lyophilised injectables, Topicals,
Effervescent tablets, Specialty medicaments like Potent drugs &
Oncology products. The company has also acquired expertise in oral
NDDS and Controlled Release pellets.
The Company has around 300 Research Professionals working on various
drug products and the departments of work force include:
Media Zone @ Astron Research